AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28547999 — intervention group
Group type: COMPARATOR
Intervention: Control group (exercise intervention in community facilities)
Number of subjects: 105
Study 26017268 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure and Response Prevention (ERP)
Number of subjects: 133
Study 26017268 — intervention group
Group type: COMPARATOR
Intervention: Control group (general non-psychotic psychiatric outpatient sample), n = 110
Number of subjects: 133
Study 23394408 — intervention group
Group type: EXPERIMENTAL
Intervention: Information film about prenatal examinations
Number of subjects: 390
Study 23394408 — intervention group
Group type: COMPARATOR
Intervention: Control group (no information film)
Number of subjects: 390
Study 21312328 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly laundered short‐sleeved uniforms
Number of subjects: 100
Study 21312328 — intervention group
Group type: COMPARATOR
Intervention: Physicians' white coats
Number of subjects: 100
Study 19058890 — intervention group
Group type: EXPERIMENTAL
Intervention: Half a year of clinical work before an ALS course
Number of subjects: 117
Study 19058890 — intervention group
Group type: COMPARATOR
Intervention: Immediate participation in an ALS course following graduation (Control)
Number of subjects: 117
Study 17376996 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigator correction
Number of subjects: 83
Study 15586803 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) 0.5% applied topically for 5 minutes after ESS
Number of subjects: 29
Study 15586803 — intervention group
Group type: COMPARATOR
Intervention: Saline (control) applied topically for 5 minutes after ESS
Number of subjects: 29
Study 11183450 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2%
Number of subjects: 28
Study 11183450 — intervention group
Group type: COMPARATOR
Intervention: Olopatadine hydrochloride 0.1%
Number of subjects: 28
Study 8979142 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged prophylaxis against postoperative venous thromboembolism
Number of subjects: 0
Study 8979142 — intervention group
Group type: COMPARATOR
Intervention: Standard prophylaxis (7-14 days)
Number of subjects: 0
Study 1424850 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific inspiratory muscle training combined with general exercise reconditioning
Number of subjects: 36
Study 1424850 — intervention group
Group type: COMPARATOR
Intervention: General exercise reconditioning alone
Number of subjects: 36
Study 1424850 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 36
Study 4050528 — intervention group
Group type: EXPERIMENTAL
Intervention: Amipaque (metrizamide)
Number of subjects: 99
Study 4050528 — intervention group
Group type: COMPARATOR
Intervention: Isopaque Coronar (meglumine-Na-Ca-metrizoate)
Number of subjects: 99
Study 30651989 — intervention group
Group type: EXPERIMENTAL
Intervention: High fidelity simulation (HF)
Number of subjects: 90
Study 30651989 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fidelity simulation (LF)
Number of subjects: 90
Study 30651989 — intervention group
Group type: COMPARATOR
Intervention: Sham simulation (S)
Number of subjects: 90
Study 30021633 — intervention group
Group type: EXPERIMENTAL
Intervention: Softec HD™ IOL (0.25 D interval)
Number of subjects: 40
Study 30021633 — intervention group
Group type: COMPARATOR
Intervention: Akreos AO IOL (0.50 D interval)
Number of subjects: 40
Study 28399988 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-SBNT (adapted youth social behaviour and network therapy)
Number of subjects: 53
Study 28399988 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 53
Study 26143666 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of SHRM at enrollment (77%), at 4 weeks (68%), and at 104 weeks (54%).
Number of subjects: 1185
Study 26143666 — intervention group
Group type: COMPARATOR
Intervention: Eyes with persistent SHRM at 104 weeks showed scar presence (64%) compared to those with resolved SHRM (31%).
Number of subjects: 1185
Study 26143666 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean VA letter scores for SHRM status: absent (73.5), present outside central 1 mm² (73.1), present within central 1 mm² but not foveal center (65.3), present at foveal center (63.9).
Number of subjects: 1185
Study 26143666 — intervention group
Group type: EXPERIMENTAL
Intervention: Median maximum SHRM height under the fovea: 86 μm (absent), 120 μm (outside central 1 mm²), 122 μm (within central 1 mm²).
Number of subjects: 1185
Study 24868255 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of fat graft, laser CO2, and platelet-rich plasma (PRP)
Number of subjects: 64
Study 20305407 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc-99m sestamibi
Number of subjects: 23
Study 20305407 — intervention group
Group type: COMPARATOR
Intervention: Tc-99m pertechnetate
Number of subjects: 23
Study 18979616 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurt containing 1 g plant sterols (Study I)
Number of subjects: 27
Study 18979616 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurt containing 2 g plant sterols (Study II)
Number of subjects: 27
Study 18979616 — intervention group
Group type: COMPARATOR
Intervention: Sterol yoghurt (combined results from both studies)
Number of subjects: 27
Study 18979616 — intervention group
Group type: COMPARATOR
Intervention: Placebo yoghurt (Study I and Study II)
Number of subjects: 27
Study 16610925 — intervention group
Group type: EXPERIMENTAL
Intervention: Recycling intervention strategy to increase tobacco dependence treatment rates
Number of subjects: 951
Study 14506832 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified lard
Number of subjects: 0
Study 14506832 — intervention group
Group type: COMPARATOR
Intervention: Lard
Number of subjects: 0
Study 14506832 — intervention group
Group type: EXPERIMENTAL
Intervention: Both meals (modified lard and lard)
Number of subjects: 0
Study 10907668 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.25, 0.50, 0.75 mg)
Number of subjects: 28
Study 10907668 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (0.75 mg)
Number of subjects: 28
Study 10907668 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 28
Study 10907668 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (5, 10, 15 mg)
Number of subjects: 28
Study 10907668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 8994313 — intervention group
Group type: EXPERIMENTAL
Intervention: HbOC
Number of subjects: 319
Study 8994313 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP-T
Number of subjects: 319
Study 8994313 — intervention group
Group type: COMPARATOR
Intervention: Interchangeable products (HbOC or PRP-T)
Number of subjects: 319
Study 8994313 — intervention group
Group type: COMPARATOR
Intervention: No specific intervention
Number of subjects: 319
Study 1451900 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac
Number of subjects: 3
Study 1451900 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg pethidine
Number of subjects: 3
Study 1451900 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg pethidine
Number of subjects: 3
Study 6499355 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (240 to 480 mg%)
Number of subjects: 24
Study 6499355 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (120 to 360 mg%)
Number of subjects: 24
Study 6499355 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (480 mg%)
Number of subjects: 24
Study 29444275 — intervention group
Group type: EXPERIMENTAL
Intervention: Health condition (harm reduction themed ads)
Number of subjects: 393
Study 29444275 — intervention group
Group type: EXPERIMENTAL
Intervention: Social condition (social enhancement themed ads)
Number of subjects: 393
Study 29444275 — intervention group
Group type: COMPARATOR
Intervention: Control condition (ads of everyday objects only)
Number of subjects: 393
Study 28268330 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherence to self-monitoring of diet and moderate adherence to glucose self-monitoring
Number of subjects: 0
Study 28268330 — intervention group
Group type: COMPARATOR
Intervention: Clusters with high or low adherence to self-monitoring of all four factors
Number of subjects: 0
Study 25543688 — intervention group
Group type: EXPERIMENTAL
Intervention: Five face-to-face counseling sessions
Number of subjects: 261
Study 25543688 — intervention group
Group type: EXPERIMENTAL
Intervention: One face-to-face counseling session followed by four telephone calls
Number of subjects: 261
Study 25543688 — intervention group
Group type: COMPARATOR
Intervention: Generic mailed physical activity brochure (usual care)
Number of subjects: 261
Study 25543688 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention group (face-to-face and telephone)
Number of subjects: 261
Study 25543688 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported physical activity
Number of subjects: 261
Study 25543688 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behavior
Number of subjects: 261
Study 25543688 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 261
Study 25543688 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 261
Study 22901398 — intervention group
Group type: EXPERIMENTAL
Intervention: Newsletter prenotification
Number of subjects: 1342
Study 22901398 — intervention group
Group type: COMPARATOR
Intervention: No newsletter prenotification
Number of subjects: 1342
Study 20384600 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg
Number of subjects: 72
Study 20384600 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine 150 mg
Number of subjects: 72
Study 20384600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 18227539 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiography and MR imaging (n = 96)
Number of subjects: 189
Study 18227539 — intervention group
Group type: COMPARATOR
Intervention: Radiography alone (n = 93)
Number of subjects: 189
Study 16317121 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavones
Number of subjects: 39
Study 16317121 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructooligosaccharides
Number of subjects: 39
Study 14612852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclo 3 Fort
Number of subjects: 10246
Study 14612852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10246
Study 10390389 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 200 micrograms twice daily (FP200)
Number of subjects: 237
Study 10390389 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 100 micrograms twice daily (FP100)
Number of subjects: 237
Study 10390389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study 8219927 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative administration of acetaminophen
Number of subjects: 0
Study 8219927 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acetaminophen)
Number of subjects: 0
Study 3691593 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 5 mg daily
Number of subjects: 36
Study 3691593 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 mg daily
Number of subjects: 36
Study 3691593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 29366431 — intervention group
Group type: EXPERIMENTAL
Intervention: 5mg prednisolone in the evening
Number of subjects: 8
Study 29366431 — intervention group
Group type: EXPERIMENTAL
Intervention: 5mg prednisolone in the morning
Number of subjects: 8
Study 27325340 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranking without sorting
Number of subjects: 600
Study 27325340 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranking and sorting
Number of subjects: 600
Study 27325340 — intervention group
Group type: COMPARATOR
Intervention: Control (present EQ-5D-5L study protocol, without ranking)
Number of subjects: 600
Study 26075375 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (HD)
Number of subjects: 160
Study 26075375 — intervention group
Group type: COMPARATOR
Intervention: Transparent polyurethane film (PF)
Number of subjects: 160
Study 23489892 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual mammography for at least 5 years
Number of subjects: 6710
Study 23489892 — intervention group
Group type: COMPARATOR
Intervention: Control group from the UK Breast Screening Age Trial
Number of subjects: 6710
Study 21681888 — intervention group
Group type: EXPERIMENTAL
Intervention: Export catheter (Medtronic, Minneapolis, MN)
Number of subjects: 201
Study 21681888 — intervention group
Group type: COMPARATOR
Intervention: X-sizer system (eV3, White Bear Lake, MN)
Number of subjects: 201
Study 19366752 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (home visits by lay community workers providing support and guidance in parenting)
Number of subjects: 449
Study 19366752 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 449
Study 19366752 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapeutic input)
Number of subjects: 449
Study 19366752 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 449
Study 16625238 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilnidipine for 2 months
Number of subjects: 40
Study 16625238 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cilnidipine)
Number of subjects: 40
Study 15162946 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled steroids (Beclomethasone) plus prolonged action bronchodilator (Salmeterol)
Number of subjects: 30
Study 15162946 — intervention group
Group type: COMPARATOR
Intervention: Inhaled steroids (Beclomethasone)
Number of subjects: 30
Study 11458057 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyestradiol phosphate (240 mg intramuscular injections every 2 weeks for 8 weeks, then monthly)
Number of subjects: 915
Study 11458057 — intervention group
Group type: COMPARATOR
Intervention: Complete androgen ablation (bilateral orchiectomy or 3.75 mg triptorelin monthly with 250 mg flutamide 3 times daily)
Number of subjects: 915
Study 10089183 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (adjusted to achieve an INR of 2.0 to 3.0)
Number of subjects: 162
Study 10089183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 10089183 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 162
Study 7917165 — intervention group
Group type: COMPARATOR
Intervention: Unweighted condition (no additional weight)
Number of subjects: 8
Study 7917165 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of 0.68 kg to the shank
Number of subjects: 8
Study 7917165 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of 1.34 kg to the shank
Number of subjects: 8
Study 7917165 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected walking speed
Number of subjects: 8
Study 7917165 — intervention group
Group type: COMPARATOR
Intervention: Control speeds (0.6, 1.0, and 1.5 m/s)
Number of subjects: 8
Study 2697567 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft (CABG) surgery
Number of subjects: 0
Study 2697567 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 0
Study 1100014 — intervention group
Group type: EXPERIMENTAL
Intervention: 5,000 international units aqueous heparin sodium
Number of subjects: 105
Study 1100014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 30456795 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard BurstDR stimulation
Number of subjects: 25
Study 30456795 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdosing A (5 sec of BurstDR alternating with 5 sec of no stimulation)
Number of subjects: 25
Study 30456795 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdosing B (5 sec of BurstDR alternating with 10 sec of no stimulation)
Number of subjects: 25
Study 30456795 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdosing A and B
Number of subjects: 25
Study 28874235 — intervention group
Group type: EXPERIMENTAL
Intervention: rhC1‐INH (50 IU/kg for patients <84 kg; 4200 IU for patients ≥84 kg)
Number of subjects: 75
Study 28874235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 28874235 — intervention group
Group type: EXPERIMENTAL
Intervention: rhC1‐INH (during OLE study)
Number of subjects: 75
Study 28874235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during OLE study)
Number of subjects: 75
Study 26083955 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Psychosocial Intervention (CPI)
Number of subjects: 180
Study 26083955 — intervention group
Group type: COMPARATOR
Intervention: Usual Community Care (UCC)
Number of subjects: 180
Study 23465176 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT) screening
Number of subjects: 333
Study 23465176 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 333
Study 21628010 — intervention group
Group type: EXPERIMENTAL
Intervention: Various endoscopic technologies (e.g., colonoscopy, third eye retroscope, cap-fitted, cap-assisted)
Number of subjects: 0
Study 21628010 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 18993031 — intervention group
Group type: COMPARATOR
Intervention: Switching to other medications from olanzapine
Number of subjects: 129
Study 18993031 — intervention group
Group type: EXPERIMENTAL
Intervention: Staying on olanzapine
Number of subjects: 129
Study 18993031 — intervention group
Group type: COMPARATOR
Intervention: Switching to other medications from risperidone
Number of subjects: 129
Study 18993031 — intervention group
Group type: EXPERIMENTAL
Intervention: Staying on risperidone
Number of subjects: 129
Study 18993031 — intervention group
Group type: COMPARATOR
Intervention: Switching from quetiapine
Number of subjects: 129
Study 18993031 — intervention group
Group type: EXPERIMENTAL
Intervention: Staying on quetiapine
Number of subjects: 129
Study 16550824 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostamol Uno 320 mg
Number of subjects: 54
Study 16550824 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 54
Study 12856138 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled ileal-release budesonide (9 mg by mouth)
Number of subjects: 26
Study 12856138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 10865008 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocardiogram (EKG)
Number of subjects: 749
Study 10865008 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest Radiogram (x-ray)
Number of subjects: 749
Study 10865008 — intervention group
Group type: COMPARATOR
Intervention: Clinical examination without EKG and x-ray
Number of subjects: 749
Study 9333132 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training (2 h/day, 5 days/week for 5 weeks)
Number of subjects: 38
Study 9333132 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 38
Study 7687421 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with hyperthermia (HCR)
Number of subjects: 21
Study 7687421 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (Group A)
Number of subjects: 21
Study 3772566 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing medical records with smokers (experimental group)
Number of subjects: 401
Study 3772566 — intervention group
Group type: COMPARATOR
Intervention: No sharing of medical records (control group)
Number of subjects: 401
Study 30197144 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 kg MR
Number of subjects: 96
Study 30197144 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 kg MR
Number of subjects: 96
Study 30197144 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.1 kg MR
Number of subjects: 96
Study 30197144 — intervention group
Group type: EXPERIMENTAL
Intervention: ad lib MR
Number of subjects: 96
Study 27585384 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 μg once daily
Number of subjects: 2354
Study 27585384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2354
Study 25201722 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS) plus maximal medical care
Number of subjects: 140
Study 25201722 — intervention group
Group type: COMPARATOR
Intervention: Maximal medical care alone
Number of subjects: 140
Study 22532945 — intervention group
Group type: EXPERIMENTAL
Intervention: Breezy candy (sugar-free) containing zinc gluconate 0.5%, propolis 2%, and a combination of both (zinc 0.25% and propolis 1%)
Number of subjects: 75
Study 22532945 — intervention group
Group type: COMPARATOR
Intervention: Regular candy (traditional candy without abrasive particles)
Number of subjects: 75
Study 20102734 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise at 60%, 85%, or 110% of concentric one repetition maxima
Number of subjects: 160
Study 20102734 — intervention group
Group type: COMPARATOR
Intervention: Resting control group
Number of subjects: 160
Study 18652115 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-Section Brocade practice for 4 months
Number of subjects: 54
Study 18652115 — intervention group
Group type: EXPERIMENTAL
Intervention: Eight-Section Brocade practice for 2 months
Number of subjects: 54
Study 16025696 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking intervention (4 times a week for 20 to 30 minutes)
Number of subjects: 173
Study 16025696 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control group
Number of subjects: 173
Study 12057549 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 10141
Study 12057549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10141
Study 10687651 — intervention group
Group type: EXPERIMENTAL
Intervention: New polymer hydrogel wound dressing
Number of subjects: 10
Study 10687651 — intervention group
Group type: COMPARATOR
Intervention: Leading market hydrocolloid dressing
Number of subjects: 10
Study 8912780 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled methacholine (intervention)
Number of subjects: 0
Study 1773266 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 40
Study 1773266 — intervention group
Group type: COMPARATOR
Intervention: Computed Tomography (CT)
Number of subjects: 40
Study 6752962 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 8